Demographic differences in prostate cancer incidence and stage: An examination of population diversity in California

American Journal of Preventive Medicine

Volumn 14, Issue 2, 1998, Pages 96-102

  Delfino, Ralph J ^a,c   Ferrini, Rebecca L ^b   Taylor, Thomas H ^a   Howe, Susan ^d   Anton Culver, Hoda ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b SAN DIEGO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER STAGING; CONTROLLED STUDY; DEMOGRAPHY; EARLY DIAGNOSIS; ETHNOLOGY; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PROSTATE CANCER; QUALITY OF LIFE; RACE DIFFERENCE; UNITED STATES;

EID: 0032004714     PISSN: 07493797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-3797(97)00014-7     Document Type: Article

References (40)

1. 1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer Statistics, 1997. CA Cancer J Clin 1997;47:5-27.
2. 2. Kosary CL, Ries LAG, Miller BA, Hankey BF, Harras A, Edwards BK, eds. SEER cancer statistics review, 1973-1992: Tables and graphs, National Cancer Institute. NIH Pub. No. 95-2789. Bethesda, Maryland, 1995.
3. 3. Potosky AL, Kessler L, Gridley G, Brown CC, Horm JW. Rise in prostatic cancer incidence associated with increased risk of transurethral resection. J Natl Cancer Inst 1990;82:1624-28.
4. 4. Potosky AL, Miller BA, Albertsen PC, Kramer BS. The role of increasing detection in the rising incidence of prostate cancer. JAMA 1995;273:548-52.
5. 5. Lu-Yao GL, McLerran D, Wasson J, Wennberg JE. An assessment of radical prostatectomy: time trends, geographic variation and outcomes. JAMA 1993;269:2633-36.
6. 6. Mettlin C, Murphy GP, Menck H. Trends in treatment of localized prostate cancer by radical prostatectomy: observations from the Commission on Cancer, National Cancer Database, 1985-1990. Urology 1994;43:488-92.
7. 7. Snipes KP, Perkins CI, Wright WE, Young JL. Cancer incidence and mortality by race/ethnicity in California 1988-1991. Sacramento, California: California Dept. of Health Services, Cancer Surveillance Section, May 1994.
8. 8. Percy C, van Holten V, Muir C, eds. International classification of diseases for oncology, 2nd ed. Bethesda, Maryland: National Cancer Institute, 1990.
9. 9. American Association of Central Cancer Registries (AACCR). Standards for completeness, quality, analysis, and management of data. Standards for cancer registries, Vol III. JE Seiffert, ed. AACCR, 1994.
10. 10. Stewart SL, Glaser SL, Horn-Ross PL, West DW. SEER study of methods to classify Hispanic cancer patients. Final Report. Contract No. 1-CN-05224. Union City, California: Northern California Cancer Center, 1993.
11. 11. Shambaugh EM, Ries LG, Young JL, et al. SEER extent of disease - 1988 codes and coding instructions. Bethesda, Maryland: National Cancer Institute, 1988.
12. 12. American Joint Committee on Cancer. Manual for staging of cancer. Philadelphia: J.B. Lippincott, 1988;177-82.
13. 13. Liu W-L, Kasl S, Flannery JT, Lindo A, Dubrow R. The accuracy of prostate cancer staging in a population-based tumor registry and its impact on the black-white stage difference (Connecticut, United States). Cancer Causes Control 1995;6:425-30.
14. 14. U.S. Bureau of the Census. 1990. 1990 Census. Washington, DC: U.S. Government Printing Office.
15. 15. U.S. Bureau of the Census (1972). 1970 Census Second Count Summary Tape. Washington, DC: U.S. Government Printing Office.
16. 16. Miettinen OS. Estimability and estimation in case-referent studies. Am J Epidemiol 1976;103:226-35.
17. 17. Liff JM, Chow WH, Greenberg RS. Rural-urban difference in stage at diagnosis - possible relationship to cancer screening. Cancer 1991;67:1454-59.
18. 18. Ragland KE, Selvin S, Merrill DW. Black-white differences in stage-specific cancer survival: analysis of seven selected sites. Am J Epidemiol 1991;133:672-82.
19. 19. Targonski PV, Guinan P, Phillips CW. Prostate cancer: the stage disadvantage in the black male. J Natl Med Assoc 1991;83:1094-96.
20. 20. Polednak AP, Flannery JT. Black versus white racial differences in clinical stage at diagnosis and treatment of prostate cancer in Connecticut. Cancer 1992;70:2152-58.
21. 21. Demers RY, Swanson GM, Weiss LK, Kau T-Y. Increasing incidence of cancer of the prostate. Arch Intern Med 1994;154:1211-16.
22. 22. Gilliland FD, Becker TM, Key CR, Samet JM. Contrasting trends of prostate cancer incidence and mortality in New Mexico's Hispanics, non-Hispanic whites, American Indians and blacks. Cancer 1994;73:2192-99.
23. 23. Danley KL, Richardson JL, Bernstein L, Langholz B, Ross RK. Prostate cancer: trends in mortality and stage-specific incidence rates by racial/ethnic group in Los Angeles County, California (United States). Cancer Causes Control 1995;6:492-98.
24. 24. Morton RA, Jr. Racial differences in adenocarcinoma of the prostate in North American men. Urology 1994;44: 637-45.
25. 25. Pienta KJ. The epidemiology of prostate cancer: clues for chemoprevention. In Vivo 1994;8:419-22.
26. 26. Meikle AW, Smith JA Jr. Epidemiology of prostate cancer. Urol Clin North Am 1990;17:709-18.
27. 27. Optenberg SA, Thompson IM, Friedrichs P, Wojcik B, Stein CR, Kramer B. Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system. JAMA 1995;274:1599-1605.
28. 28. Levy IG, Gibbons L, Colins JP, Perkins DG, Mao Y. Prostate cancer trends in Canada: rising incidence or increased detection? Can Med Assoc J 1993;149:617-24.
29. 29. Lu-Yao GL, Greenberg ER. Changes in prostate cancer incidence and treatment in USA. Lancet 1994;343:251-54.
30. 30. Perkins CI, Morris CR, Wright WE. Cancer incidence and mortality in California by race/ethnicity, 1988-1993. Sacramento, California: California Dept. of Health Services, Cancer Surveillance Section, March 1996.
31. 31. Severson RK. Have transurethral resections contributed to the increasing incidence of prostatic cancer? J Natl Cancer Inst 1990;82:1597-98.
32. 32. Catalona WJ, Smith DS, Ratliff TL, Basler JW. Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA 1993; 270:948-54.
33. 33. Fleming C, Wasson JH, Albertsen PC, Barry MJ, Wennberg JE. A decision analysis of alternative treatment strategies for clinically localized prostate cancer: Prostate Patient Outcomes Research Team. JAMA 1993;269:2650-58.
34. 34. Harlan L, Brawley O, Pommerenke F, Wall P, Kramer B. Geographic, age, and racial variation in the treatment of localized/regional carcinoma of the prostate. J Clin Oncol 1995;13:93-100.
35. 35. Chodak GW, Thisted RA, Gerber GS, et al. Results of conservative management of clinically localized prostate cancer. N Engl J Med 1994;330:242-48.
36. 36. Dhom G. Epidemiologic aspects of latent and clinically manifest carcinoma of the prostate. J Cancer Res Clin Oncol 1983;106:210-18.
37. 37. Whitmore WF, Jr. Management of clinically localized prostatic cancer: an unresolved problem. JAMA 1993;269: 2676-77.
38. 38. Kramer BS, Brown ML, Prorok PC, Potosky AL, Gohagan JK. Prostate cancer screening: what we know and what we need to know. Ann Int Med 1993;119:914-23.
39. 39. Krahn MD, Mahoney JE, Eckman MH, Trachtenberg J, Pauker SG, Detsky AS. Screening for prostate cancer: a decision analytic view. JAMA 1994;272:773-80.
40. 40. Wilt TJ, Brawer MK. The prostate cancer intervention versus observation trial: a randomized trial comparing radical prostatectomy versus expectant management for the treatment of clinically localized prostate cancer. J Urol 1994;152:1910-14.